Press Releases Biomm S.A.

Equities

BIOM3

BRBIOMACNOR2

Market Closed - Sao Paulo Other stock markets 04:06:00 2024-04-29 pm EDT			5-day change	1st Jan Change
17.77 ^BRL	+10.99%		+8.62%	+207.44%

Apr. 18	Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil	MT
Apr. 17	Biocon Limited Signs an Exclusive Licensing and Supply Agreement with Biomm S.A	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biomm S A : Webcast Presentation 3Q23	Nov. 14	PU
Biomm S A : Apresentação de resultados 2T23	23-08-09	PU
Biomm S A : Presentation of 1Q22 Results	22-05-15	PU
Biomm S A : Comunicado ao Mercado	22-03-03	PU
CytoDyn : Receives Clearance from Brazil's FDA (ANVISA) to Commence a Pivotal Phase 3 Trial in Critically Ill COVID-19 Patients with IV Administration of Four Doses (700mg/week)	21-09-23	AQ
CytoDyn : Receives Clearance from Brazil's ANVISA to Commence Phase 3 Trial for Severe COVID-19 Patients	21-08-04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer